Steve Jobs reprend ses activités à la tête d'Apple

[Uniweb]

Steve Jobs souhaite s'éloigner d'Apple jusque fin Juin, pour s'occuper de sa santé, qui lui cause plus de soucis qu'il ne l'avait d'abord dit

C'est Tim Cook qui assurera l'interim en attendant le retour d'iPapy.

Steve Jobs ayant pendant des années basé l'image d'Apple sur sa personnalité, ses keynotes, la Bourse a, hier, immédiatement réagi en faisant perdre 8 % à l'action d'Apple

[STEF]

Jobs had a procedure similar to a Whipple operation, which involves removing parts of the pancreas, bile duct and small intestine, after he was diagnosed with a rare type of pancreatic cancer in 2004. A potential side effect of this procedure is that the organ has to be removed to prevent pancreatic leak, and the patient has to be kept alive with insulin to regulate blood sugar, said Robert Thomas, head of surgery at the Peter MacCallum Cancer Centre in Melbourne.
“You might have to take the rest of the pancreas out,” said Thomas, 66, who first performed the Whipple’s procedure more than 20 years ago. “You’re on significant doses of insulin, and it’s not easy to manage. The person has the risk of severe diabetes.”
Jobs, who handed day-to-day operations to Chief Operating Officer Tim Cook, said he will remain involved in “major strategic decisions.”

Jobs disclosed in August 2004 that he had surgery to remove a tumor related to a rare form of pancreatic cancer that wouldn’t require chemotherapy or radiation. Cook ran Apple while Jobs took a monthlong leave.
Jobs told Apple’s board about his cancer and directors decided to say nothing, Fortune reported in March 2008. Larry Sonsini, the company’s attorney, told directors that Jobs’s right to privacy topped disclosure rules, the magazine said. Sonsini declined to comment yesterday.

Last week, Jobs said he was suffering a hormone imbalance that had caused him to lose weight and that the remedy is “relatively simple.”
‘Incomplete’
That disclosure “will strike many as incomplete,” in light of yesterday’s announcement, said John Coffee, a securities law professor at Columbia Law School in New York.
The U.S. Securities and Exchange Commission may examine whether Jobs or Apple purposely misled investors about his condition, Coffee said. If the stock drops dramatically, shareholders may sue, Coffee said.

http://www.bloomberg.com/apps/news?p...sIA&refer=home

[Uniweb]

Après avoir subi récemment une transplantation, Steve Jobs retourne travailler chez Apple, et reprend son rôle en tant que CEO.